Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of belladonna and opium suppository for postoperative stent pain in nephrolithiasis patients completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • belladonna and opium suppository

Snippet

Sponsor: University of Washington | Conditions: Nephrolithiasis | Phase 4 | Status: COMPLETED | Results posted: 2023-06-18